 | Up a level |
Obmann, Verena Carola; Marx, Christina Lynn; Berzigotti, Annalisa; Mertineit, Nando; Hrycyk, Joris; Gräni, Christoph; Ebner, Lukas; Ith, Michael; Heverhagen, Johannes; Christe, Andreas; Huber, Adrian Thomas (2019). Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis. European journal of radiology, 118, pp. 66-74. Elsevier 10.1016/j.ejrad.2019.07.001
Pöllinger, Alexander; Hrycyk, Joris (2019). Erdheim-Chester Disease. Mayo Clinic proceedings, 94(5), pp. 924-925. Elsevier 10.1016/j.mayocp.2019.01.026
Hrycyk, Joris; Heverhagen, Johannes; Böhm, Ingrid (2019). What you should know about prophylaxis and treatment of radiographic and magnetic resonance contrast medium extravasation. Acta radiologica, 60(4), pp. 496-500. Sage 10.1177/0284185118782000
Hrycyk, Joris; Obmann, Verena Carola; Marx, Christina Lynn; Kadji, W; Catucci, D; Berzigotti, Annalisa; Ebner, Lukas; Christe, Andreas; Huber, Adrian Thomas (July 2020). Liver vein to cava attenuation: a simple parameter to increase predictive value of caudate-right lobe ratio and liver segmental volume ratio to detect significant liver fibrosis on abdominal CT scans (Unpublished). In: ECR 2020. Vienna. July 15-19, 2020.
Catucci, D; Obmann, Verena Carola; Berzigotti, Annalisa; Hrycyk, Joris; Kadji, W; Gräni, Christoph; Ebner, Lukas; Christe, Andreas; Huber, Adrian Thomas (July 2020). Mapping of the liver function - impact of MR field strength on T1 reduction rate (Unpublished). In: ECR 2020. Vienna. July 15-19, 2020.
Catucci, D; Obmann, Verena Carola; Berzigotti, Annalisa; Hrycyk, Joris; Kadji, W; Gräni, Christoph; Ebner, Lukas; Heverhagen, Johannes; Christe, Andreas; Huber, Adrian Thomas (22 May 2020). Mapping of the liver function - impact of MR field strength on T1 reduction rate (Unpublished). In: ESGAR 2020. Amsterdam, The Netherlands. May 19 - 22, 2020.
Hrycyk, Joris (May 2020). “Liver vein to cava attenuation (LVCA): a simple parameter to increase predictive value of caudate-right lobe ratio (CRL-R) and liver segmental volume ratio (LSV-R) to detect significant liver fibrosis on portal venous phase abdominal CT scans” (Unpublished). In: ESGAR 2020, Amsterdam.
Hrycyk, Joris; Pöllinger, Alexander; Geiling, Katharina (2 December 2019). Drug-induced lung disease in precision cancer therapy (Unpublished). In: RSNA'2019.
Obmann, Verena Carola; Marx, Christina Lynn; Hrycyk, Joris; Ebner, Lukas; Ith, Michael; Gräni, Christoph; Berzigotti, Annalisa; Heverhagen, Johannes; Christe, Andreas; Huber, Adrian Thomas (June 2019). Liver MRI susceptibility-weighted imaging (SWI) and T2 mapping in the presence of steatosis and fibrosis (Unpublished). In: ESGAR. Rom. June 2019.
Marx, Christina; Obmann, Verena; Hrycyk, Joris; Ebner, Lukas; Berzigotti, Annalisa; Heverhagen, Johannes; Christe, Andreas; Huber, Adrian (June 2019). Liver vein to cava attenuation (LVCA) improves prediction of clinically significant fibrosis when combined with liver volumetry and caudate-right lobe ratio (crl-r) on portal venous CT scans. In: Swiss Congress of Radiology, SCR, SGR-SSR, St. Gallen.
Hrycyk, Joris; Heverhagen, Johannes; Böhm, Ingrid (June 2019). Extravasion of contrast media: update of essentials to manage the patient (Unpublished). In: Swiss Congress of Radiology, SCR.
Hrycyk, Joris; Nairz, Knud; Böhm, Ingrid (2019). Warum die Prämedikation manchmal versagt (Unpublished). In: 100. Deutscher Röntgenkongress. Leipzig. 29. Mai - 1. Juni 2019.
